Platelet transfusions play a major role in the management of thrombocytopenia in hematological and oncologic patients. However, a proportion of these patients become refractory to the transfusion ...

3 Clinical and Population Perinatal Health Research, Kolling Institute, University of Sydney, Sydney, New South Wales, Australia Objectives This study aimed to describe the use of red cells, platelets ...

Results: Three of 78 patients (4%) developed anti-D antibodies after receiving RhD-incompatible platelet transfusions. One of the patients developed evidence of anti-RhD antibodies after receiving ...

His condition disrupts the production of blood cells, meaning he has to get platelet transfusions. “I don’t make platelets.

22.9), mortality was lower in this group (41%versus 53%) Conclusions Epoprostenol as the sole anti-haemostatic agent for CRRT increases mean filter life, decreases bleeding risk without increasing ...